GlaxoSmithKline (GSK)
42.92
-0.75 -1.72%
NYSE
Sep 29, 16:59
Delayed 2m
USD
View All Key Stats
GSK Key Stats
| Income Statement | |
| Revenue (TTM) | 37.33B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.0118 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 75.54M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 67.48% |
| Profit Margin (Quarterly) | -6.66% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 5.14% |
| Price and Valuation | |
| Market Cap | 104.56B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 2.811 |
| PE Ratio (TTM) | 3644.70 |
| Price to Book Value | 135.32 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | 34.12 |
| Free Cash Flow (Quarterly) | 1.090B |
| Return on Equity (TTM) | 1.21% |
View All GSK News
GSK News
-
WireHeadlineTime (ET)
-
MT Newswires09/29 09:02
-
Yahoo09/29 04:16
-
Yahoo09/28 15:14
-
Yahoo09/28 13:58
-
MT Newswires09/28 12:28
-
Yahoo09/28 12:21
-
Yahoo09/28 09:55
-
SA Breaking News09/28 09:46
-
Yahoo09/28 09:30
-
Yahoo09/28 09:29
View All Events
GSK Events
| Date | Type | Description |
|---|---|---|
| 10/26/2016 | Earnings | GlaxoSmithKline PLC Third Quarter Earnings Results in 2016 |
| 08/10/2016 | Dividends | Amount: 0.4992, Declared Date: Jul 27 2016, Pay Date: Oct 13 2016 |
| 07/27/2016 | Earnings | GlaxoSmithKline PLC Second Quarter Earnings Results in 2016 |
| 05/11/2016 | Dividends | Amount: 0.5002, Declared Date: Apr 28 2016, Pay Date: Jul 14 2016 |
| 05/05/2016 | Misc | GlaxoSmithKline PLC Annual General Meeting in 2015 |
| 04/27/2016 | Earnings | GlaxoSmithKline PLC First Quarter Earnings Results in 2016 |
| 03/17/2016 | Misc | GlaxoSmithKline PLC Annual Report in 2015 |
| 02/17/2016 | Dividends | Amount: 0.6561, Declared Date: Feb 16 2016, Pay Date: Apr 14 2016 |
| 02/17/2016 | Dividends | Amount: 0.5705, Declared Date: Feb 03 2016, Pay Date: Apr 14 2016 |
| 02/03/2016 | Earnings | GlaxoSmithKline PLC Fourth Quarter Earnings Results in 2015 |
GSK Fundamentals
Income Statement View Statement
GSK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Investment Strategies Featuring GSK
Did GlaxoSmithKline make it into our Investment Strategies?
Start your YCharts membership now to find out.
Edit
Profile
- URL: http://www.gsk.com
- Investor Relations URL: http://www.gsk.com/en-gb/investors/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Next Earnings Release: October 26, 2016
- Last Earnings Release: July 27, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: August 10, 2016
- Description: GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products.
GSK Comparables
EditGSK Excel Add-In Codes
- Name: =YCI("GSK","name")
- Description: =YCI("GSK","description")
- Sector: =YCI("GSK","sector")
- Industry: =YCI("GSK","industry")
- Est. Current Fiscal Year End: =YCI("GSK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other GSK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GSK Tweets Stocktwits
Advertisement